Onasemnogene Abeparvovec: Post-infusion Efficacy and Safety in Patients With Spinal Muscular Atrophy (SMA)-A Fondazione Policlinico Gemelli IRCCS Experience.
Hosp Pharm
; 59(1): 39-46, 2024 Feb.
Article
in En
| MEDLINE
| ID: mdl-38223869
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Aspects:
Patient_preference
Language:
En
Journal:
Hosp Pharm
Year:
2024
Document type:
Article
Affiliation country:
Italia
Country of publication:
Estados Unidos